BPG is committed to discovery and dissemination of knowledge
Retrospective Study
©The Author(s) 2026.
World J Gastrointest Oncol. Jan 15, 2026; 18(1): 112742
Published online Jan 15, 2026. doi: 10.4251/wjgo.v18.i1.112742
Table 10 Train-of-Four monitoring and neuromuscular blockade effect evaluation
Indicator
Sarcopenia group (n = 35)
Non-sarcopenia group (n = 65)
t-test
P value
Time to TOF count = 0 for intubation (min)2.3 ± 0.43.0 ± 0.6-6.284< 0.001
First supplemental dose time (min)42.8 ± 10.258.4 ± 12.8-6.124< 0.001
TOF ratio recovery to 0.7 time (min)55.2 ± 11.875.6 ± 16.2-6.486< 0.001
TOF ratio recovery to 0.9 time (min)65.8 ± 13.689.2 ± 18.8-6.824< 0.001
Intubation condition score (excellent rate %)100100--


Write to the Help Desk